According to Statifacts, the global Immunoassay market size is calculated at USD 32,820 million in 2024 and is expected to reach around USD 53,970 million by 2034, growing at a CAGR of 5.1% for the ...

PORTLAND, IA, UNITED STATES, February 13, 2025 /EINPresswire / -- LFIA based rapid test market is anticipated to exhibit growth owing to increase in incidence of infectious disease, rise in awareness ...

Archimed has invested heavily in the invitro diagnostics sector in recent years. Before acquiring Diesse in July 2019, the ...

Archimed sold Diesse for €125 million in January, after spending six years expanding the company through internationalization and innovation.

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

The global immunodiagnostics market size is calculated at USD 24.20 billion in 2025 and is expected to reach around USD 70.9 ...

The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.

Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...

State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Jilin, Changchun 130022, China ...

NeuroDex's recent paper (link) describes the development of a novel multiplexed immunoassay designed to detect surface-exposed proteins on plasma extracellular vesicles (EVs). The new assay provides ...

The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...